Xin Delu Sheng Recombinant Human Interleukin-2 Injection Instructions for Use

The Xin Delu Sheng Recombinant Human Interleukin‑2 Injection manual provides dosage, indications, contraindications, storage, and safety information.


Xin Delu Sheng Recombinant Human Interleukin-2 Injection Instructions for Use - cover page
Brand
新德路生
Category
Health Care
Document type
Product Leaflet
Language
Chinese
Pages
4
File format
PDF
File size
174 KB
Published
28 September, 2026
Updated
28 September, 2026
MD5 checksum
141725A60A91D005C87270E8B1B09968

About this manual

Recombinant Human Interleukin‑2 Injection (重组人白介素-2注射液) is an immunomodulatory drug used for the biological treatment of various malignant tumors, including kidney cancer, malignant melanoma, and malignant pleural or peritoneal effusions. The product is supplied as a clear sterile solution in glass vials or pre‑filled syringes.

The instructions detail recommended dosing (20‑100 万 IU/m² daily by intravenous, subcutaneous or intramuscular injection), contraindications, common adverse reactions such as fever and chills, storage conditions (2‑8 °C, protected from light), and handling precautions. It also includes information on use in pregnancy, pediatric and elderly patients, and emergency measures for overdose. This manual is written in Chinese.

What's inside

  • Composition
  • Physical Characteristics
  • Indications
  • Dosage and Administration
  • Adverse Reactions
  • Contraindications
  • Precautions
  • Pregnancy and Lactation
  • Storage and Shelf Life
  • Regulatory Information

Specifications

Dosage formTransparent sterile solution
pH3.5 ~ 4.5
Strength (vial)50万 IU/0.4 ml per vial
Strength (syringe)100万 IU/0.8 ml per pre‑filled syringe
Storage temperature2 ~ 8 °C, protected from light
Shelf life24 months
Packaging (vial)Glass vial, 1 vial per box
Packaging (syringe)Pre‑filled syringe, 1 per box
Approval number (50万 IU/vial)国药准字S20040007号

Frequently asked questions

What are the most common adverse reactions?

The most common adverse reactions are fever, chills, and muscle aches; other possible effects include nausea, vomiting, rash, and local injection site redness or pain.

Who should not receive this injection?

Patients with a known allergy to any component, high fever, severe heart disease, low blood pressure, severe cardiac‑renal dysfunction, lung disease, organ transplant recipients, or a history of severe toxicity to IL‑2 should not use the product.

How should the product be stored?

Store the injection at 2 ~ 8 °C, protected from light, and do not exceed 7 days at room temperature during transport.

What is the recommended dosage for cancer treatment?

Typical dosing is 20‑100 万 IU per square meter of body surface area once daily for four weeks; intrathoracic or intraperitoneal administration may be 50‑100 万 IU/m² 1‑2 times per week for 2‑4 weeks.

Download PDF (174 KB)